Clinical Outcomes of Chronic Myeloid Leukaemia (CML) Patients on Asciminib Through the Managed Access Program (MAP) in Australia
INTERNAL MEDICINE JOURNAL（2024）
Key words
asciminib,chronic myeloid leukaemia,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined